Investing in a bull market isn't always as straightforward as it seems. It's easy to find stocks that are doing well during a bull run, but some end up rising too much, too fast, leading to significant corrections once things turn sour.

Finding stocks that aren't keeping pace with broader equities can be a decent strategy, provided there are good reasons to think these corporations can turn things around and deliver solid returns over the long run. Let's discuss two beaten-down stocks worth buying in this ongoing bull market: Johnson & Johnson (NYSE: JNJ) and Doximity (NYSE: DOCS).

Johnson & Johnson has been around for over a century, but that's no guarantee it will continue to thrive for a long time. In recent years, the drugmaker has dealt with more and more legal challenges, including thousands of lawsuits related to its talc-based products that allegedly gave consumers cancer.

Continue reading

Source Fool.com